{{noteTA
|T=zh-hant:鹽酸西替利嗪; zh-hans:盐酸西替利嗪
|G1=Cetirizine
|G2=Chemistry
|G3=Medicine
}}
{{medical}}
{{Drugbox
| verifiedrevid = 460026203
| IUPAC_name = (±)-[2-[4-[(4-chlorophenyl)phenylmethyl]-1- piperazinyl]ethoxy]acetic acid
| image = Cetirizine structure.svg
| imagename = Cetirizine
| image2 = Cetirizine ball-and-stick animation.gif
| drug_name = 鹽酸西替利嗪<br>{{lang|en|Cetirizine }}
<!--Clinical data-->
| tradename = Zyrtec
| Drugs.com = {{drugs.com|monograph|cetirizine-hydrochloride}}
| MedlinePlus = a698026
| licence_EU =  
| licence_US = Cetirizine
| pregnancy_US = B
| legal_UK = GSL
| legal_US = OTC
| legal_status = OTC in Canada
| routes_of_administration = [[口服|口服]]

<!--Pharmacokinetic data-->
| bioavailability = 吸收性很好
| protein_bound = ~93%
| metabolism = 排泄性基本不變
| elimination_half-life = 8.3 小時
| excretion = 尿液(主要)、肝臟或排便(少量)

<!--Identifiers-->
| CASNo_Ref = {{cascite|correct|CAS}}
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 83881-51-0
| ATC_prefix = R06
| ATC_suffix = AE07
| PubChem = 2678
| IUPHAR_ligand = 1222
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
 | DrugBank = DB00341
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 2577
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = YO7261ME24
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07662
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 3561
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1000

<!--Chemical data-->
| C=21 | H=25 | Cl=1 | N=2 | O=3 
| molecular_weight = 388.89
| smiles = Clc1ccc(cc1)C(c2ccccc2)N3CCN(CC3)CCOCC(=O)O
| InChI = 1/C21H25ClN2O3/c22-19-8-6-18(7-9-19)21(17-4-2-1-3-5-17)24-12-10-23(11-13-24)14-15-27-16-20(25)26/h1-9,21H,10-16H2,(H,25,26)
| InChIKey = ZKLPARSLTMPFCP-UHFFFAOYAC
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C21H25ClN2O3/c22-19-8-6-18(7-9-19)21(17-4-2-1-3-5-17)24-12-10-23(11-13-24)14-15-27-16-20(25)26/h1-9,21H,10-16H2,(H,25,26)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = ZKLPARSLTMPFCP-UHFFFAOYSA-N
| synonyms = Alerid, Alatrol, Alzene, Cetirizina, Cetirin, Cetzine, Cetirizin, Cezin, Histazine, Humex, Letizen, Razene, Reactine, Zyrtec, Zirtec, Zodac, Zirtek, Zynor, Zyrlek, Zyllergy
}}
[[File:Cetrizine_Enantiomers_Structural_Formulae.png|thumb]]

'''盐酸西替利{{ruby|嗪|-{zh-hans:qín;zh-tw:ㄑㄧㄣˊ;zh-hk:ceon4}-}}'''（{{lang-en|Cetirizine}}）是一种抗[[过敏|过敏]]药，又稱去敏定、司特寧、仙特明、協帝、CETIN或CETY，它是第二代H1[[抗組織胺藥|抗組織胺藥]]，为长效的具选择性的[[口服|口服]]强效抗過敏反应药。

治疗[[过敏性鼻炎|过敏性鼻炎]]、由过敏原引起的[[荨麻疹|荨麻疹]]及[[皮膚炎|皮肤瘙痒]]有较好疗效。

在中国大陆，自2008年1月11日起，盐酸西替利嗪由[[处方药|处方药]]转换为[[非处方药|非处方药]]。<ref>{{Cite web |url=http://www.sda.gov.cn/WS01/CL0288/27532.html |title=关于盐酸西替利嗪片等30种药品转换为非处方药的通知 |access-date=2008-07-02 |archive-url=https://web.archive.org/web/20090108181116/http://www.sda.gov.cn/WS01/CL0288/27532.html |archive-date=2009-01-08 |dead-url=yes }}</ref>在香港以'''治敏速'''的名字由[[葛蘭素史克|葛蘭素史克]]以非處方藥發售。某些人或對鹽酸西替利嗪產生[[昏睡|昏睡]]的[[副作用|副作用]]，故第一次服用該藥物建議避免駕駛交通工具或操作機器等。

==相關製劑==
與[[二氫氯化物|二氫氯化物]](di-hydrochloride; 二鹽酸化物、二鹽酸鹽)形成{{le|組合藥劑|Combination drug}}(combination drug)「思得寧」、「去敏定」(Cetirizine dihydrochloride 10mg/長效型之抗過敏及抗組織胺藥、台灣南光化學製藥)。<ref>抗組織胺,"Cetirizine dihydrochloride 10mg(長效型之抗過敏及抗組織胺藥)"[http://mab.mnd.gov.tw/med/efiles/A043502100.pdf] {{Wayback|url=http://mab.mnd.gov.tw/med/efiles/A043502100.pdf |date=20140221063700 }}[http://www.nangkuang.com.tw/index.php?option=product&lang=cht&task=pageinfo&id=200&belongid=198&index=1] {{Wayback|url=http://www.nangkuang.com.tw/index.php?option=product&lang=cht&task=pageinfo&id=200&belongid=198&index=1 |date=20181004163430 }},南光化學製藥股份有限公司,retrieved Jan.26,2014.</ref>

==註釋==
{{reflist}}

==參考書籍及期刊==
{{refbegin}}
# Anderson, P. O., Knoben, J. E., et al. (2002) ''Handbook of clinical drug data 10th ed.'' McGraw-Hill International
# Pfizer Inc, et al. (2006) ''ZYRTEC  (cetirizine hydrochloride) Tablets, Chewable Tablets and Syrup For Oral Use'' Pfizer Incorporated publications
# Chetrit, E. B., Amir, G., Shalit, M. (2005). ''Cetirizine: an effective agent in Kimura's Disease'' Arthritis & Rheumatism (Arthritis care & research) Vol 53, p117-118
{{refend}}

==參見==
*[[氯化物|氯化物]](chloride；鹽酸鹽)
*{{le|氫氯化物|Hydrochloride}}(hydrochloride)

==外部連結==
{{Portal|醫學}}
*[https://web.archive.org/web/20070927213033/http://www.pfizer.com/pfizer/download/uspi_zyrtec.pdf Zyrtec prescribing information] [[Pfizer|Pfizer]]
*[http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm109025.htm US FDA approves Zyrtec-D for over the counter sales] {{Wayback|url=http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm109025.htm |date=20161022203148 }}
*[http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm109033.htm US FDA approves Zyrtec for over the counter sales] {{Wayback|url=http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm109033.htm |date=20161022203142 }}
* [http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=Cetirizine U.S. National Library of Medicine: Drug Information Portal - Cetirizine] {{Wayback|url=http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=Cetirizine |date=20150603040221 }}
* {{cite web | url = https://druginfo.nlm.nih.gov/drugportal/name/cetirizine | publisher = U.S. National Library of Medicine | work = Drug Information Portal | title = Cetirizine | access-date = 2020-07-27 | archive-date = 2021-03-28 | archive-url = https://web.archive.org/web/20210328172540/https://druginfo.nlm.nih.gov/drugportal/name/cetirizine | dead-url = no }}

{{Antihistamines}}
{{Histaminergics}}
{{tsl|en|Template:PAF receptor modulators}}

[[Category:H1受体拮抗剂|Y]]
[[Category:哌嗪|Category:哌嗪]]
[[Category:辉瑞|Category:辉瑞]]
[[Category:强生公司|Category:强生公司]]
[[Category:醚|Category:醚]]
[[Category:有机氯化合物|Category:有机氯化合物]]
[[Category:羧酸|Category:羧酸]]
[[Category:輝瑞產品|Category:輝瑞產品]]
[[Category:缺少物质图片的化学品条目|Category:缺少物质图片的化学品条目]]